Navigation Links
FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Date:10/19/2009

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The safety and effectiveness of Fluarix for use in children ages 3 years and older is documented by a U.S. study comparing 2,115 children who received Fluarix with 1,210 children who received Fluzone, a different influenza vaccine already licensed by the FDA for use in children ages 6 months and older. Study results showed that children 3 years and older vaccinated with Fluarix and Fluzone produced similar amounts of antibodies in the blood at levels considered likely to be protective against seasonal influenza.

Fluarix is a seasonal influenza vaccine not intended to protect against the 2009 H1N1 influenza virus.

"This approval of an additional seasonal influenza vaccine for children provides help in protecting them against influenza," said Karen Midthun, M.D., acting director of the FDA's Center for Biologics Evaluation and Research. "Children are very vulnerable to the influenza virus and are more likely to be hospitalized for associated problems."

With today's approval, there are now four companies approved by the FDA to manufacture seasonal influenza vaccine for use in children.

Influenza is far more dangerous than the common cold for children, who often require medical care, especially if they are younger than 5 years. It is best to vaccinate children each fall, but vaccination also can occur in the winter months when influenza season often peaks.

Common adverse events experienced after administration
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves New Treatment for Advanced Form of Kidney Cancer
2. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
3. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
4. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
5. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
6. FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
7. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
9. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
10. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
11. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... MINNEAPOLIS , March 3, 2015  Uroplasty, ... company that develops, manufactures and markets innovative proprietary ... meeting for shareholders and analysts on Thursday, March ... at Uroplasty,s corporate headquarters in Minnetonka ... , President and Chief Executive Officer, will host ...
(Date:3/3/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announces that ... will be making a corporate presentation at the 27th ... Dana Point, CA.  Dr. Ren will present on March ...
(Date:3/2/2015)... , March 2, 2015 Cure SMA recently announced ... of Biomedical Research (CALIBR). This funding is an extension of ... with a $700,000 Cure SMA grant to Dr. Peter ... program, "Optimization of Small Molecules that Increase SMN2 ... Survival motor neuron (SMN) protein is critical to the function ...
Breaking Medicine Technology:Uroplasty to Host Investor Meeting at Corporate Headquarters 2Uroplasty to Host Investor Meeting at Corporate Headquarters 3Uroplasty to Host Investor Meeting at Corporate Headquarters 4Uroplasty to Host Investor Meeting at Corporate Headquarters 5Uroplasty to Host Investor Meeting at Corporate Headquarters 6CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3
... late 2008 or early 2009 -, SAN CARLOS, ... today announced that it has enrolled the first patient ... tolerability and,pharmacokinetics of bolus plus infusion dosing of NU172, ... "We were very encouraged by the findings of ...
... MOUNTAIN VIEW, California, June 4 BN,ImmunoTherapeutics, Inc. ... vaccine candidate against prostate cancer., A Phase ... patients with,non-metastatic as well as hormone-insensitive prostate cancer ... the trial include examining,the ability of the vaccine ...
Cached Medicine Technology:Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172 2Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172 3BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2
(Date:3/3/2015)... Angeles, CA (PRWEB) March 03, 2015 ... Boost , a fast weight loss product that is ... country. This is because it contains ingredients that help ... Boost is a new combination diet product thought to ... Metabolism Boost contains three ingredients, all directed at ...
(Date:3/3/2015)... Getting to the truth of the matter is ... at stake. So when it comes to physical therapy – ... – it’s vital to separate fact from fiction in order ... Sridhar Yalamanchili, PT, MSPT, and Director of Rehabilitation at ... nationwide survey by the American Physical Therapy Association (APTA) revealed ...
(Date:3/3/2015)... Spain (PRWEB) March 03, 2015 The authors ... best health care for the future is a good and ... by Xlibris UK) the authors have a created an ingenious ... & cooked vegetarian & vegan meals. , “Crude Food” ... food intolerances and allergies, mainly caused by over processed ...
(Date:3/3/2015)... HealthCarePoint (HCP) , the ... today that it has completed development of the ... Standards Consortium (CDISC). HCP will continue to provide ... training and certifications globally. HCP’s in-kind services will ... as well as development of dynamic identification for ...
(Date:3/3/2015)... 03, 2015 Motion Graphics ... of a new plugin FCPX3D Confetti designed exclusively for ... exploding transition using confetti particles inside FCPX,” said Christina ... FCPX3D Confetti transition, users will have fun as they ... from one clip to the next with 3D tumbling ...
Breaking Medicine News(10 mins):Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:Separating Fact from Fiction about Physical Therapy 2Health News:Separating Fact from Fiction about Physical Therapy 3Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2
... News) -- Premature infants have fewer types of bacteria in ... However, the bacteria and other microbes often found ... researchers from Duke University Medical Center noted. "You see ... they seem to be stuck -- they have fewer types ...
... function were common and long-lasting during the first ... to a new study from Johns Hopkins University ... risk factor for impaired physical function. "Early ... evaluated as a potential,intervention to improve long-term outcomes ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Increased consumption ... of breast cancer recurrence, new research finds. Researcher ... University of California, San Diego, looked at changes in ... potatoes, that breast cancer survivors ate over a one-year ...
... quantifying the amount of three different HER growth proteins, ... breast cancer , did not predict a patient,s outcome ... Herceptin, say Mayo Clinic researchers. HER2-positive breast cancer gets ... factor receptor 2 that promotes cancer cell growth. ...
... By Serena Gordon HealthDay Reporter , THURSDAY, Dec. ... the risk of stroke dropped about 22 percent in people ... These people didn,t yet have high blood pressure, but they ... significant reduction in the rate of heart attacks for people ...
... used to spot where people live, satellite images of ... festering among them, too, according to new research. ... Dec. 9 that nighttime-lights imagery presents a new ... revealing the population boom that typically coincides with seasonal ...
Cached Medicine News:Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2Health News:Depressive symptoms and impaired physical function are frequent and long-lasting after ALI 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 3Health News:Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 3Health News:Princeton study: Nighttime images help track disease from the sky 2Health News:Princeton study: Nighttime images help track disease from the sky 3Health News:Princeton study: Nighttime images help track disease from the sky 4Health News:Princeton study: Nighttime images help track disease from the sky 5Health News:Princeton study: Nighttime images help track disease from the sky 6
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... EMR,systems require you to,change the ... only,electronic patient charting,solution designed to ... around,five specific criteria to,enhance overall ... you to see,more patients in ...
... StatStrip point-of-care glucose monitor elevates bedside glucose ... performance that approaches the quality of central ... well glucose measuring strip technology. Current ... Novas exclusive Multi-Well system measures and corrects ...
... EMS provides service to companies in many ... stores and restaurants.There are no hidden charges at ... equipment and service are among the lowest in ... array of services ranging from MasterCard/Visa processing to ...
Medicine Products: